Journal article
Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation
Pratishtha Chatterjee, Michelle Tegg, Steve Pedrini, Anne M Fagan, Chengjie Xiong, Abhay K Singh, Kevin Taddei, Samantha Gardener, Colin L Masters, Peter R Schofield, Gerhard Multhaup, Tammie LS Benzinger, John C Morris, Randall J Bateman, Steven M Greenberg, Mark A van Buchem, Erik Stoops, Hugo Vanderstichele, Charlotte E Teunissen, Graeme J Hankey Show all
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | MDPI | Published : 2021
DOI: 10.3390/ijms22062931
Abstract
Plasma amyloid-beta (Aβ) has long been investigated as a blood biomarker candidate for Cerebral Amyloid Angiopathy (CAA), however previous findings have been inconsistent which could be attributed to the use of less sensitive assays. This study investigates plasma Aβ alterations between pre-symptomatic Dutch-type hereditary CAA (D-CAA) mutation-carriers (MC) and non-carriers (NC) using two Aβ measurement platforms. Seventeen pre-symptomatic members of a D-CAA pedigree were assembled and followed up 3-4 years later (NC = 8; MC = 9). Plasma Aβ1-40 and Aβ1-42 were cross-sectionally and longitudinally analysed at baseline (T1) and follow-up (T2) and were found to be lower in MCs compared to NCs,..
View full abstractGrants
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by National Institute of Health (NIH)
Funding Acknowledgements
This study was funded by the National Health and Medical Research Council (NHMRC) project grant APP1129627 and National Institute of Health (NIH) grant for the Dominantly Inherited Alzheimer Network study U19AG032438.